← Back to Search

Device

Active Transcranial Direct Stimulation for Brain Fog (tDCS Trial)

N/A
Waitlist Available
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the feasibility and effectiveness of using transcranial direct current stimulation to help improve cognitive functioning in people with cognitive impairments.

Eligible Conditions
  • Brain Fog

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility and acceptability after 4 weeks of daily tDCS use

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial Direct StimulationExperimental Treatment1 Intervention
Subjects will receive an active electrical stimulation device (tDCS) to use up to 20 minutes daily for 4 weeks. To deliver tDCS subjects will place a strap around their forehead area.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Transcranial Direct Stimulation
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,022 Previous Clinical Trials
6,029,251 Total Patients Enrolled
~3 spots leftby Nov 2025